As providers increasingly turn to weight-loss medications for conditions like metabolic dysfunction-associated steatotic liver disease (MASLD), a new review published in the
Weight Loss Medications Show Promise in MASLD, MASH
As providers increasingly turn to weight-loss medications for conditions like metabolic dysfunction-associated steatotic liver disease (MASLD), a new review published in the